Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuro-Oncology

• Publication date

  2009-03-29

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s11060-009-9873-9PMID 19330482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extent of Resection and Survival in Glioblastoma Multiforme.

  2009cited by this paper
• Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

  2009cited by this paper
• EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS

  2008cited by this paper
• Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence

  2008cited by this paper
• Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

  2008influential reference
• Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury

  2007cited by this paper
• Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

  2007cited by this paper
• Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005influential reference
• Stereotactic radiosurgery (SRS)

  2005cited by this paper
• The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.

  2005influential reference
• Adjuvant Gamma Knife Stereotactic Radiosurgery at the Time of Tumor Progression Potentially Improves Survival for Patients with Glioblastoma Multiforme

  2005influential reference
• Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

  2005influential reference
• Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.

  2004influential reference
• Does Stereotactic Eligibility for the Treatment of Glioblastoma Cause Selection Bias in Randomized Studies?

  2004cited by this paper
• Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy.

  2004cited by this paper
• A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

  2003cited by this paper
• Salvage therapy in patients with glioblastoma

  2003cited by this paper
• Gamma Knife Stereotactic Radiosurgery for Patients with Glioblastoma Multiforme

  2002influential reference
• Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

  2000cited by this paper
• Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.

  1999cited by this paper
• Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

  1999influential reference
• Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

  1998influential reference
• Beneficial effects of the radioprotectant 21-aminosteroid U-74389G in a radiosurgery rat malignant glioma model.

  1998cited by this paper
• Measuring Bias in Uncontrolled Brain Tumor Trials – to Randomize or Not to Randomize?

  1997cited by this paper
• Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

  1997cited by this paper
• Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery.

  1997influential reference
• Isolation and characterization of human malignant glioma cells from histologically normal brain.

  1997cited by this paper
• Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

  1995cited by this paper
• Stereotactic radiosurgery for recurrent malignant gliomas.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995cited by this paper
• 1002 An analysis of acute complications and perioperative morbidity from high dose rate brachytherapy in the treatment of gynecological malignancies

  1995cited by this paper
• Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

  1994cited by this paper
• Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

  1993cited by this paper
• Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.

  1993cited by this paper
• Radiosurgery as part of the initial management of patients with malignant gliomas.

  1992cited by this paper
• Selection bias, survival, and brachytherapy for glioma.

  1992cited by this paper
• Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas.

  1989cited by this paper
• Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

  1989cited by this paper
• Assumptions in the radiotherapy of glioblastoma

  1980cited by this paper
• An analysis of dose-effect relationship in the radiotherapy of malignant gliomas.

  1979cited by this paper

• International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines for Radiosurgery in Recurrent High-Grade Glioma.

  2025cites this paper
• Gamma Knife radiosurgery for primary and recurrent glioblastoma: Systematic review and meta-analysis with target- and protocol-based stratification.

  2025cites this paper
• Efficacy of combined therapy with gamma knife radiosurgery and bevacizumab on survival outcomes in patients with recurrent high-grade glioma: a systematic review and meta-analysis

  2025cites this paper
• PET-CT Guided Gamma Knife Radiosurgery for Recurrent Glioblastoma Multiforme Recurrent Cases in Pakistan

  2023cites this paper
• Role of Stereotactic Radiosurgery in Glial Tumors

  2023cites this paper
• Synthesis and characterization of rutin-loaded micelles for glioblastoma multiforme treatment: A computational and experimental study

  2023cites this paper
• High grade gliomas.

  2022cites this paper
• Current status and recent advances in reirradiation of glioblastoma

  2021cites this paper
• Radiosurgery for Glioblastoma.

  2021cites this paper
• Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.

  2021cites this paper
• Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma

  2021cites this paper
• Stereotactic Radiosurgery for Recurrent Glioblastoma Multiforme

  2020cites this paper
• Role of Gamma Knife Radiosurgery in the Management of Intracranial Gliomas

  2020cites this paper
• Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis

  2020cites this paper
• Long-term outcome data from 121 patients treated with Gamma Knife stereotactic radiosurgery as salvage therapy for focally recurrent high-grade gliomas.

  2019cites this paper
• Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up

  2019cites this paper
• Stereotactic Radiosurgery for Glial Tumors

  2019cites this paper
• Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.

  2019cites this paper
• Diagnosis and management of multiple high-grade gliomas: a retrospective study

  2019cites this paper
• Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma.

  2019cites this paper
• Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma

  2018cites this paper
• MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma

  2017cites this paper
• Brain tumors - other treatment modalities.

  2017cites this paper
• 14 Stereotactic Radiosurgery for Gliomas

  2017cites this paper
• Survival and complications of stereotactic radiosurgery

  2017cites this paper
• To B(iopsy) or not to B(iopsy).

  2017cites this paper
• Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience

  2016cites this paper
• Glioblastoma: Multidisciplinary treatment approaches

  2016cites this paper
• Gamma Knife Radiosurgery in Recurrent Glioblastoma

  2016cites this paper
• Chapter 8 – Principles and Tenets of Radiation Treatment in Glioblastoma

  2016cites this paper
• Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation

  2016cites this paper
• Stereotactic Radiosurgery and Radiotherapy in the Management of High-Grade Gliomas

  2015cites this paper
• Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

  2015cites this paper
• Stereotactic Radiosurgery for Glioblastoma

  2015cites this paper
• Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience

  2015cites this paper
• Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas

  2015cites this paper
• Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma

  2015cites this paper
• Applications of Nanomaterials in Radiotherapy for Malignant Tumors.

  2015cites this paper
• Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis

  2015cites this paper
• Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma.

  2014cites this paper
• Case Series: Gamma Knife as Salvage Therapy for Recurrent Glioblastoma

  2014cites this paper
• Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.

  2014cites this paper
• Clinical Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma

  2014cites this paper
• Survival Following Stereotactic Radiotherapy for Recurrent High Grade Gliomas

  2014cites this paper
• Salvage Radiosurgery for Selected Patients with Recurrent Malignant Gliomas

  2014cites this paper
• WITHAFERIN A: A NOVEL THERAPEUTIC APPROACH FOR MALIGANT BRAIN TUMORS

  2014cites this paper
• MRI tumor response and clinical outcomes after LINAC radiosurgery on 50 patients with recurrent malignant gliomas.

  2013influential citation
• Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors

  2013cites this paper
• Stereotactic radiosurgery for high-grade gliomas: available evidence and the need for further investigation.

  2013cites this paper
• Stereotactic radiosurgery for intracranial gliomas.

  2013cites this paper
• Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature

  2013cites this paper
• Gamma Knife Radiosurgery for High Grade Glial Neoplasms: A Canadian Experience

  2013cites this paper
• Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme

  2013cites this paper
• Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.

  2013cites this paper
• Extended field stereotactic radiosurgery for recurrent glioblastoma

  2012cites this paper
• Glioblastoma multiforme: overview of current treatment and future perspectives.

  2012cites this paper
• Stereotactic radiosurgery for glioblastoma--time to revisit this approach.

  2012cites this paper
• γ knife surgery versus reoperation for recurrent glioblastoma multiforme.

  2012cites this paper
• The emerging role of stereotactic radiosurgery in the treatment of glioblastoma multiforme.

  2012cites this paper
• Outcomes after stereotactic radiosurgery and various adjuvant treatments for recurrent glioblastoma multiforme: a current literature review and comparison of multiple factors that impact outcome.

  2012cites this paper
• The role of adjuvant radiation therapy in the management of high-grade gliomas.

  2012cites this paper
• Radiosurgery for high-grade glioma

  2012cites this paper
• Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study

  2012cites this paper
• Management of multifocal and multicentric gliomas.

  2012cites this paper
• External Beam Radiotherapy of Recurrent Glioma: Radiation Tolerance of the Human Brain

  2012cites this paper
• Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma.

  2012cites this paper
• Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas

  2012cites this paper
• Stereotactic radiosurgery for recurrent high-grade gliomas.

  2011cites this paper
• PerspectiveStereotactic Radiosurgery for Recurrent High Grade Gliomas

  2011cites this paper
• Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma

  2011cites this paper
• Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.

  2011cites this paper
• Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.

  2011cites this paper
• Stereotactic Radiosurgery for Gliomas

  2011influential citation
• Metalloporphyrin antioxidants ameliorate normal tissue radiation damage in rat brain

  2010cites this paper
• Gliomas in adults.

  2010cites this paper
• Combining drugs and radiotherapy: from the bench to the bedside

  2009cites this paper
• Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme.

  2009cites this paper